64,631 results found

On November 7, 2024, the PCAOB posted the agenda for its Standards and Emerging Issues Advisory Group meeting, which will take place on November 12 at 9:00 a.m. ET and will be livestreamed on the PCAOB's website.

The SEC initiated administrative proceedings against a partner of an accounting firm who served as "engagement partner" for the independent audits of a venture capital fund.

After more than a year of transition, both the DOJ and FTC have fully appointed leadership in place.

The European Commission's draft new EU Merger Guidelines and the UK's evolving approach signal a shift in how mergers are analyzed amid changing geopolitical dynamics. Partner James K. Hunsberger joins Brunswick's Stuart Hudson and Matthew Hall to explore what these regulatory changes mean for merger control, examining potential EU/UK convergence or divergence and the growing risk of politicization in competition reviews.

McDermott's Antitrust M&A Snapshot is a resource for in-house counsel and others who deal with antitrust M&A issues but are not faced with these issues on a daily basis

The proposed Paramount-Warner Bros. transaction reveals a fundamental shift in global merger review dynamics, where U.K. regulators now wield unprecedented influence over American media deals. This analysis explores how the Competition and Markets Authority's expanding jurisdictional reach and distinct antitrust standards create new strategic challenges for multinational companies.

The FTC's record-setting $12 million settlement with Edwards Lifesciences and Genesis MedTech raises critical questions about deal structuring and Hart-Scott-Rodino Act compliance. When does strategic transaction design cross the line into intentional avoidance of premerger notification requirements? Leading antitrust practitioners examine the implications of this landmark enforcement action for deal teams navigating transactions near HSR thresholds.

On Sept. 25, 2013, the Federal Trade Commission and the Department of Justice issued an updated joint model waiver of confidentiality for individuals and companies to use in merger and non-merger matters.

The Federal Trade Commission has once again announced that it will delay enforcement of the Red Flags Rules until June 1, 2010, as applicable to financial institutions and creditors.

Promoting competition among health care providers remains a top priority for the Federal Trade Commission and it is expected that the FTC will continue to challenge mergers in the health care industry.

On December 6, 2013, a federal judge sentenced the former president of SeaStar Line LLC to five years in prison for his role in a price-fixing conspiracy – the longest-ever prison sentence imposed for an antitrust violation.

In news related to non-competition agreements, proposed constitutional changes in Georgia could make it much easier to enforce this type of agreement in that state.

David Reichenberg contributed an article to Forbes discussing why certain companies have chosen to go public via SPAC

David Reichenberg was quoted in a Global Competition Review article that discusses how the Federal Trade Commission and Department of Justice have said they intend to jointly review their merger

Healthcare companies face intensifying antitrust scrutiny as regulators adapt their enforcement strategies to address evolving industry dynamics. What are the three critical risk areas that healthcare organizations must monitor in 2026, and how are changing enforcement priorities reshaping regulatory oversight across the sector?

Antitrust law today is the subject of intense public and political focus. Scrutiny of M&A activity in particular continues to be an area of priority for federal antitrust enforcers.